Chinese patent medicine is expected to fill the gap in the treatment of American liver disease

Chinese medicine, formed and developed in thousands of years of experience and practice, is being accepted by more and more countries and people Recently, at the 2013 American annual meeting of liver diseases held in Washington, D.C., the "Fuzheng Huayu" tablet, a compound Chinese patent medicine of anti liver fibrosis from China, attracted the special attention of experts attending the meeting The "Fuzheng Huayu" tablet independently developed by Shanghai Modern Chinese Medicine Co., Ltd has successfully passed the most critical phase II clinical trial in the United States After the phase III clinical trial, it will become the first Chinese medicine to be listed in western countries This will not only fill the gap in the field of anti fibrosis treatment in the United States, but also open up new ideas for the internationalization of traditional Chinese medicine The United States is a country with high incidence of hepatitis C according to the data of centers for Disease Control and prevention, there are about 3.2 million people infected with hepatitis C in the United States Professor Tarek Hassani, director of the clinical trial center of the medical center of the University of California, San Diego, and head of the second phase clinical trial group of the United States of America for Fuzheng Huayu tablet, told our reporter that for western medicine, the United States has not developed effective drugs to control or even reverse liver fibrosis After the second phase of clinical trial, it was found that "Fuzheng Huayu" tablet can improve the liver fibrosis of chronic hepatitis C, and it has high safety and good tolerance, which is expected to fill the gap of Western medicine in this field Hassani pointed out that traditional Chinese medicine has a long history and rich clinical experience If you want to enter the western mainstream market on a large scale, you must pass strict scientific evaluation and officially go on the market as a prescription medicine As an integral part of the strategy of Chinese culture going out, the internationalization of traditional Chinese medicine has been perplexing experts, scholars and entrepreneurs in this field At this annual meeting of liver diseases, the reporter met Professor Liu Ping, one of the main researchers of "strengthening the body and removing blood stasis", vice president of Shanghai University of traditional Chinese medicine According to Professor Liu, it is very important to explore an effective way to combine traditional Chinese medicine and modern western medicine from basic research to clinical trials, aiming at the weak links of modern medicine and giving full play to the traditional advantages of traditional Chinese medicine At present, Chinese medicine is still in the primary stage of going abroad Due to cultural differences, Western patients are still unfamiliar with the philosophy system of Chinese medicine, which leads to their exclusion of Chinese medicine At this time, we need to put the clinical effect of traditional Chinese medicine in the first place Once patients experience the good curative effect of traditional Chinese medicine, they are easy to accept the philosophy system of traditional Chinese medicine, so as to realize the sustainable development of the internationalization of traditional Chinese medicine Bian fossil, general manager of Shanghai Modern Medicine Co., Ltd., told reporters that "Fuzheng Huayu" tablet summed up three valuable experiences in the process of international market promotion: first, establish the market strategy of dislocation competition, select the potential vacancy in the market, give full play to the director of traditional Chinese medicine to fill in the blank field of Western Medicine Second, we should focus on the international market, especially the mainstream market in the west, focus on breaking through a little and establish an international brand This is also an effective way to disperse investment risks; third, improve the awareness of intellectual property protection of products and enhance international competitiveness Before the "Fuzheng Huayu" tablet entered the US market, the company had registered a patent for the product in the US In recent years, Shanghai Modern Medicine Co., Ltd has obtained four invention patent licenses in the United States, Europe and Canada What China's medical and pharmaceutical industry shows to the international market is openness, cooperation, responsibility, quality and efficiency.